John Toso

2.4k total citations · 2 hit papers
24 papers, 2.0k citations indexed

About

John Toso is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, John Toso has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 6 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in John Toso's work include Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (7 papers) and HIV Research and Treatment (5 papers). John Toso is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (7 papers) and HIV Research and Treatment (5 papers). John Toso collaborates with scholars based in United States, United Kingdom and India. John Toso's co-authors include Charles R. Rinaldo, Víctor Pinto-Plata, Hana Müllerová, Rupert Vessey, Douglas J. Schwartzentruber, Kathleen E. Morton, Nicholas P. Restifo, John Mao, Vee J. Gill and Richard M. Sherry and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

John Toso

23 papers receiving 2.0k citations

Hit Papers

Phase I Study of the Intravenous Administration of Attenu... 2002 2026 2010 2018 2002 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma
    2002 565 citations John Toso, Vee J. Gill et al. Journal of Clinical Oncology profile →
  2. Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma
    2002 514 citations John Toso Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Toso United States 16 986 717 655 582 361 24 2.0k
Simon D. Scott United Kingdom 24 218 0.2× 119 0.2× 154 0.2× 516 0.9× 509 1.4× 67 1.9k
Jeong‐Im Sin South Korea 22 128 0.1× 69 0.1× 1.1k 1.7× 135 0.2× 371 1.0× 51 1.6k
Michael Santosuosso Canada 17 69 0.1× 143 0.2× 1.4k 2.2× 135 0.2× 578 1.6× 22 2.5k
Sergey Gorlatov United States 20 240 0.2× 51 0.1× 752 1.1× 67 0.1× 813 2.3× 30 2.4k
Nitya Nair United States 15 86 0.1× 91 0.1× 680 1.0× 82 0.1× 340 0.9× 28 1.2k
Oliver Wildner Germany 25 197 0.2× 27 0.0× 365 0.6× 1.1k 2.0× 1.0k 2.8× 61 2.0k
Claire Coeshott United States 15 112 0.1× 45 0.1× 522 0.8× 73 0.1× 468 1.3× 26 1.1k
Roberto De Pascalis United States 18 55 0.1× 54 0.1× 721 1.1× 149 0.3× 531 1.5× 32 1.4k
Bernadette Ferraro United States 14 102 0.1× 44 0.1× 360 0.5× 64 0.1× 460 1.3× 18 1.1k
Morris Ling United States 26 84 0.1× 20 0.0× 1.8k 2.8× 329 0.6× 879 2.4× 38 2.5k

Countries citing papers authored by John Toso

Since Specialization
Citations

This map shows the geographic impact of John Toso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Toso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Toso more than expected).

Fields of papers citing papers by John Toso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Toso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Toso. The network helps show where John Toso may publish in the future.

Co-authorship network of co-authors of John Toso

This figure shows the co-authorship network connecting the top 25 collaborators of John Toso. A scholar is included among the top collaborators of John Toso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Toso. John Toso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Zhaohua, et al.. (2024). A Bayesian Hybrid Design With Borrowing From Historical Study. Pharmaceutical Statistics. 24(2). e2466–e2466. 1 indexed citations
2.
Cavalcante, Ludimila, Lillian L. Siu, John Toso, et al.. (2023). 375TiP A phase I, 2-part, multicenter, first-in-human dose-escalation and dose-expansion study of DS-1103a with trastuzumab deruxtecan (T-DXd) in patients with advanced solid tumors. Annals of Oncology. 34. S333–S333. 1 indexed citations
3.
Simpkins, Fiona, Aurea E. Flores, Christina Chu, et al.. (2013). Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study. Cancer Immunology Research. 1(3). 168–178. 41 indexed citations
4.
Robertson, Michael J., Justin Kline, Herbert Struemper, et al.. (2013). A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma. Journal of Immunotherapy. 36(6). 331–341. 29 indexed citations
5.
Srivastava, Shivani, David Y. Lewis, Zdenka Hašková, et al.. (2013). Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin. Cancer Immunology Immunotherapy. 62(6). 1073–1082. 55 indexed citations
6.
Choy, Ernest, Feng Liu, Maria Feeney, et al.. (2013). Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials. Arthritis Research & Therapy. 15(5). R132–R132. 38 indexed citations
7.
Robertson, Michael J., John W. Bauman, Olivia Gardner, et al.. (2011). Phase I Trial Evaluating the Safety and Biological Activity of Iboctadekin (rhIL-18) in Combination with Rituximab in Patients with CD20+ B Cell Non-Hodgkin's Lymphoma,. Blood. 118(21). 3697–3697. 1 indexed citations
8.
Robertson, M. J., Jessica R. Bauman, Zdenka Jonak, et al.. (2009). A phase I trial evaluating the safety and biological activity of iboctadekin (rhIL-18) in combination with rituximab in patients with CD20+ B-cell non-Hodgkin's lymphoma. Journal of Clinical Oncology. 27(15_suppl). 8566–8566. 2 indexed citations
9.
Pinto-Plata, Víctor, John Toso, Karen Lee, et al.. (2007). Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 62(7). 595–601. 164 indexed citations
10.
Pinto-Plata, Víctor, Hana Müllerová, John Toso, et al.. (2006). C-reactive protein in patients with COPD, control smokers and non-smokers. 1(3). 102–102. 77 indexed citations
11.
Toso, John, Vee J. Gill, Patrick Hwu, et al.. (2002). Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma. Journal of Clinical Oncology. 20(1). 142–152. 565 indexed citations breakdown →
12.
Toso, John, Réjean Lapointe, & Patrick Hwu. (2002). CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells. Journal of Immunological Methods. 259(1-2). 181–190. 7 indexed citations
13.
Lapointe, Réjean, John Toso, Cherié Butts, Howard A. Young, & Patrick Hwu. (2000). Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. European Journal of Immunology. 30(11). 3291–3298. 76 indexed citations
14.
Chinnasamy, Nachimuthu, Dhanalakshmi Chinnasamy, John Toso, et al.. (2000). Efficient Gene Transfer to Human Peripheral Blood Monocyte-Derived Dendritic Cells Using Human Immunodeficiency Virus Type 1-Based Lentiviral Vectors. Human Gene Therapy. 11(13). 1901–1909. 74 indexed citations
15.
16.
17.
Toso, John, et al.. (1995). Oligoclonal CD8 Lymphocytes from Persons with Asymptomatic Human Immunodeficiency Virus (HIV) Type 1 Infection Inhibit DIV-1 Replication. The Journal of Infectious Diseases. 172(4). 964–973. 40 indexed citations
18.
Ferbas, John, John Toso, Alison Logar, J Navrátil, & Charles R. Rinaldo. (1994). CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection.. The Journal of Immunology. 152(9). 4649–4662. 129 indexed citations
19.
Yasumura, S, Hirohisa Hirabayashi, D. R. Schwartz, et al.. (1993). Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.. PubMed. 53(6). 1461–8. 84 indexed citations
20.
Rappocciolo, Giovanna, John Toso, David J. Torpey, Phalguni Gupta, & Charles R. Rinaldo. (1989). Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. Journal of Clinical Microbiology. 27(1). 41–48. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon D. Scott Breakdown of academic impact, for papers by Jeong‐Im Sin Breakdown of academic impact, for papers by Michael Santosuosso Breakdown of academic impact, for papers by Sergey Gorlatov Breakdown of academic impact, for papers by Nitya Nair Breakdown of academic impact, for papers by Oliver Wildner Breakdown of academic impact, for papers by Claire Coeshott Breakdown of academic impact, for papers by Roberto De Pascalis Breakdown of academic impact, for papers by Bernadette Ferraro Breakdown of academic impact, for papers by Morris Ling
Rankless by CCL
2026